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RESEARCH ARTICLE
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ABSTRACT
Objective: To evaluate the precipitating factors for heart failure decompensation in primary
care and associations with short-term prognosis. Design Prospective cohort study with a 30-d
follow-up from an index consultation. Regression models to determine independent factors
associated with hospitalisation or death.
Setting: Primary care in ten European countries. Patients Patients with diagnosis of heart failure
attended in primary care for a heart failure decompensation (increase of dyspnoea, unexplained
weight gain or peripheral oedema).
Main outcome measures: Potential precipitating factors for decompensation of heart failure
and their association with the event of hospitalisation or mortality 30 d after a decompensation.
Results: Of 692 patients 54% were women, mean age 81 (standard deviation [SD] 8.9) years;
mean left ventricular ejection fraction (LVEF) 55% (SD 12%). Most frequently identified heart fail-
ure precipitation factors were respiratory infections in 194 patients (28%), non-compliance of
dietary recommendations in 184 (27%) and non-compliance with pharmacological treatment in
157 (23%). The two strongest precipitating factors to predict 30 d hospitalisation or death were
respiratory infections (odds ratio [OR] 2.8, 95% confidence interval [CI] (2.4–3.4)) and atrial fibril-
lation (AF) > 110 beats/min (OR 2.2, CI 1.5–3.2). Multivariate analysis confirmed the association
between the following variables and hospitalisation/death: In relation to precipitating factors:
respiratory infection (OR 1.19, 95% CI 1.14–1.25) and AF with heart rate > 110 beats/min (OR
1.22, 95% CI 1.10–1.35); and regarding patient characteristics: New York Heart Association
(NYHA) III or IV (OR 1.22, 95% CI 1.15–1.29); previous hospitalisation (OR 1.15, 95% CI 1.11–1.19);
and LVEF < 40% (OR 1.14, 95% CI 1.09–1.19).
Conclusions: In primary care, respiratory infections and rapid AF are the most important precipi-
tating factors for hospitalisation and death within 30d following an episode of heart failure
decompensation.
KEY POINTS
 Hospitalisation due to heart failure decompensation represents the highest share of health-
care costs for this disease.
 So far, no primary care studies have analysed the relationship between precipitating factors
and short term prognosis of heart failure decompensation episodes.
 We found that in 692 patients with heart failure decompensation in primary care, the respira-
tory infection and rapid atrial fibrillation (AF) increased the risk of short-term hospital admis-
sion or death.
 Patients with a hospital admission the previous year and a decompensation episode caused
by respiratory infection were even more likely to be hospitalized or die within 30 d.
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Introduction
Heart failure is a chronic disease that affects approxi-
mately 1–2% of the population [1]. Its prevalence is
increasing due to an aging population and therapeutic
advances, among other factors [2]. The epidemio-
logical dimension of heart failure, its clinical complex-
ity and impact on patients’ quality of life all constitute
a challenge for healthcare professionals. Moreover, the
financial burden that it represents for a health system
with limited resources makes this disease one of the
greatest health, organisational and economic issues
facing medical services globally [3]. Heart failure pro-
gression is characterised by increasingly frequent epi-
sodes of decompensation that often require
hospitalisation [4], the greatest contributor to health-
care costs attributed to this disease [1,3]. There are a
number of precipitating factors that can cause an epi-
sode of heart failure decompensation. The most fre-
quent are respiratory infection, transgression in dietary
recommendations, non-compliance with pharmaco-
logical treatment, hypertension and cardiac arrhyth-
mias. Up to two thirds of these are avoidable, and
timely identification could both improve disease man-
agement and reduce associated costs [5,6]. On aver-
age, heart failure patients attend their primary care
centres more than 25 times a year, and their decom-
pensations are often initially treated in these units [1].
In addition, primary care patients present greater
comorbidity, the consultations and prescriptions gen-
erally including more than one pathology [7]. Most of
those acutely admitted to hospital for common severe
emergency diagnoses have been in contact with their
family doctors during the month and year prior to
admission [8]. All of the above, highlights the key role
family doctors play in the care of such individuals.
There is, however, a lack of information regarding pre-
cipitating factors in the prognosis of patients treated
for heart failure decompensation in primary care.
Evidence concerning the impact of such factors on
decompensation episodes, mortality and hospital-
admissions is largely based on data collected in hos-
pital emergency rooms [9,10].
The objective of this study was, therefore, to iden-
tify the most frequent decompensation precipitating
factors and analyse their association with short-term
prognosis defined as hospitalisation/death within 30 d
from an index consultation date.
Methods
The HEFESTOS is an international prospective cohort
study focused on identifying the precipitating factors
involved in heart failure decompensation in primary
care. In addition, it aims to create a predictive prog-
nostic model in heart failure patients suffering from a
decompensation episode.
The study was originally designed in Spain where a
pilot study was carried out to test feasibility. Initially,
30 patients who had presented 13 events in one pri-
mary healthcare centre were recruited.
The protocol was presented in a meeting of the
European General Practice Research Network where
family doctors from nine countries agreed to collabor-
ate. The European investigators then gathered in order
to standardise the methodological procedures and
extend the study to different countries. The study
protocol was written in English with funding for trans-
lations to other languages.
Patients registered as having heart failure (accord-
ing to the European Society of Cardiology criteria) [11]
and attended in primary care centres, or managed by
primary care physicians in home care, because of
heart failure decompensation, were consecutively
recruited in ten European countries. Recruitment was
performed by 117 primary care physicians and nurses
in Spain (72), France (12), Ireland (1), Germany (2), Italy
(6), Slovenia (4), Croatia (16), Bulgaria (8), Hungary (1)
and Sweden (3). Heart failure decompensation was
considered as such when the patient presented any of
the following: increase of dyspnoea, unexplained
weight gain or appearance/increase of periph-
eral oedema.
Data on the following were collected: age, sex and
comorbidity including hypertension, diabetes mellitus,
hypercholesterolemia, ischemic heart disease, perman-
ent atrial fibrillation (AF), chronic renal failure and
stroke. New York Heart Association (NYHA) functional
class, time from commencement of symptoms until
primary care consultation, hospitalisation due to heart
failure in the year prior to decompensation, left ven-
tricular ejection fraction (LVEF) and precipitating fac-
tors were also assessed.
The following precipitating factors were taken into
consideration if they appeared concomitantly with
decompensation:
 Dietary transgression: if the patient reported liquid
intake of more than 2.5 l a day and/or added salt
to the food.
 Respiratory infection. Diagnosis was made by clin-
ical exploration and confirmed in the med-
ical records.
 Non-compliance with pharmacological treatment
(self-reported).
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 AF with a frequency > 110 beats per minute (bpm)
requiring treatment or emergency referral.
 Other infections: signs and symptoms of infections
other than respiratory ones.
 Cardiac ischemia: clinical and electrocardiographic
signs of ischaemia that required changes in treat-
ment or emergency referral.
 Intake of drugs associated with heart failure
decompensation: non-steroidal anti-inflammatory
drugs, effervescent tablets, corticosteroids, tricyclic
antidepressants.
 Other precipitants: anaemia, worsening of renal
function, hypertensive crisis, changes in diur-
etic treatment.
The primary outcomes were hospitalisation due to
cardiovascular causes and/or mortality from any cause
in the 30 d following the index consultation date. They
were verified through consulting medical records and/
or by phone.
Statistical analyses
Categorical data are expressed using frequencies and
percentages, while continuous data are expressed
using means and standard deviations (SD). A chi-
square test was used to compare data when it was
categorical. A Student’s t-test was used for
independent groups. Binary logistic regression analy-
ses were used to investigate the effect of the charac-
teristics of patients and precipitating factors in the
primary outcome. Variables significantly (p < .05) asso-
ciated with the primary outcome in the bivariate ana-
lysis were included as potential covariates in logistic
regression models. Analyses were performed using R
project version 3.6.0 (R Foundation for Statistical
Computing, Vienna, Austria) [12].
Results
Between August 2015 and December 2018, a total of
692 patients from ten countries were included.
Women represented 55% of the participants and
mean age was 81.2 (SD 8.90) years. Mean LVEF was
55% (SD 12%). The average time between consultation
and onset of symptoms was 9.1 d (SD 9.1).
Among the 692 patients evaluated, 195 (28%) were
hospitalised and 24 (3.5%) died during the first month
following the decompensation episode. Table 1
describes the characteristics of patients according to
the presence/absence of primary outcome.
At least one precipitating factor was identified in
156 (78%) of the 200 events, only one in 84 events
(42%), two in 45 events (22%) and three or more in 27
events (14%). The most frequently identified precipi-
tating factors were: respiratory infection (28%),
Table 1. Baseline characteristics in the study population.
Total
N¼ 692
No hospitalisation/death at 30 d
N¼ 492
Hospitalisation/death at 30 d
N¼ 200
p ValueN (%) N (%) N (%)
Sex:
Men 315 (45.5) 221 (44.9) 94 (47.0) Ref.
Women 377 (54.5) 271 (55.1) 106 (53.0) .437
Age, yearsa 81.2 (8.9) 81.2 (8.92) 81.2 (8.87) .818
Body mass index, kg/m2a 30.3 (6.3) 30.3 (6.35) 30.5 (6.20) .900
Diabetes mellitus 309 (44.7) 209 (42.6) 100 (50.0) <.001
Cardiac ischaemia 263 (38.2) 187 (38.2) 76 (38.0) .939
Chronic or paroxysmal atrial fibrillation 387 (56.1) 273 (55.7) 114 (57.0) .821
Stroke 96 (13.9) 71 (14.5) 25 (12.5) .296
Chronic renal disease 292 (42.3) 201 (41.0) 91 (45.5) .148
Smoker 68 (9.90) 51 (10.5) 17 (8.50) .147
Chronic obstructive pulmonary disease 204 (29.6) 135 (27.6) 69 (34.5) .013
Hypertension 584 (88.8) 413 (88.2) 171 (90.0) .056
Dyslipidaemia 373 (56.9) 255 (54.7) 118 (62.1) <.001
NHYAb <.001
I or II 188 (27.2) 163 (33.3) 25 (12.5) –
III or IV 502 (72.8) 327 (66.7) 175 (87.5) –
Hospital admission last year due to heart failure 175 (25.4) 105 (21.4) 70 (35.4) <.001
Ejection fraction
>¼ 50% 376 (73.4) 277 (77.2) 99 (64.7) Ref.
40–49% 58 (11.3) 38 (10.6) 20 (13.1) .109
<¼ 39% 78 (15.2) 44 (12.3) 34 (22.2) .000
unknown 180 (26.0) 133 (27.0) 47 (23.5) .154
ACE inhibitor/ARB 513 (74.9) 351 (71.9) 162 (82.2) <.001
Betablockers 469 (68.4) 325 (66.5) 144 (73.1) .215
Aldosterone antagonist 156 (22.9) 103 (21.2) 53 (27.0) <.001
Loop diuretics 499 (73.0) 345 (71.0) 154 (77.8) .068
aMean (standard deviation).
bNHYA: New York Heart Association functional class.
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transgression of dietary recommendations (27%) and
non-compliance with pharmacological treatment
(23%). Table 2 describes the precipitating according to
the presence/absence of primary outcome.
In univariate analysis, patients suffering from a
respiratory infection, or AF with a heart rate >110
beats/min, had a significantly higher probability of
hospitalisation/death (OR 2.84, 95% CI 2.39–3.38) and
(OR 2.17, 95% CI 1.49–3.16), respectively. In contrast,
patients with dietary transgression had a lower prob-
ability of hospitalisation/death (OR 0.51, 95% CI
0.36–0.74). Regardless of the characteristics of patients;
patients hospitalised during the previous year, pre-
senting a history of diabetes mellitus, chronic
obstructive pulmonary disease (COPD), hypercholester-
olemia, LVEF < 40% or functional stage NYHA III or IV,
treatment with ACE/or aldosterone antagonist had a
higher probability of hospitalisation/death in the first
30 d following the episode (Table 3).
A multivariate analysis including underlying patient
characteristics confirmed the association between the
following variables and hospitalisation/death. With
respect to precipitating factors: respiratory infection
(OR 1.19, 95% CI 1.14–1.25) and AF with heart rate
>110 beats/min (OR 1.22, 95% CI 1.10–1.35); and in
relation to patient characteristics: NYHA III or IV (OR
1.22, 95% CI 1.15–1.29); previous hospitalisation (OR
1.15, 95% CI 1.11–1.19); and LVEF < 40% (OR 1.14,
95% CI 1.09–1.19) (Table 3).
These variables, with and without hospitalisation
for heart failure the year before the consultation, were
analysed separately, including interactions in the
multivariate model. It was observed that hospitalisa-
tion in the previous year due to heart failure inter-
acted with respiratory infection and dietary
transgression. The probability of hospitalisation/death
from an episode precipitated by respiratory infection
was much greater if there had been a previous hospi-
talisation (OR 7.20, 95% CI 5.61; 9.25) than if there had
not (OR 2.10, 95% CI 1.75; 2.53). Dietary transgression
reduced the probability of an adverse event, although
only in those who had not been previously hospital-
ised (OR 0.40, 95% CI 0.28; 0.58) (Table 4).
Discussion
Statement of principal findings
Among the 692 patients from ten European countries
presenting an episode of heart failure decompensation
in primary care, in more than three out of four cases
at least one precipitating factor was identified, the
most frequent being respiratory infection. In addition,
respiratory infection and rapid AF were associated
with a high probability hospitalisation/death within
30 d which occurred in 29% of the decompensa-
tion episodes.
Strengths and limitations
A major strength of this study is its prospective cohort
design and international perspective (patients were
recruited from ten European countries). A selection
bias, however, could have occurred since the more
severely ill subjects might have been identified.
Nevertheless, the primary care physicians responsible
for recruitment were instructed to consecutively
include any patient with decompensated heart failure.
Due to the low percentage of patients who died we
could not analyse hospitalisation and death separately,
consequently the main outcome was a combination
of both.
Some studies [13] have shown that in primary care
there is up to a third of heart failure overdiagnosis. To
avoid such an issue, researchers were urged to only
include patients who strictly met the clinical and echo-
cardiographic criteria of the current European guide-
lines, despite the fact that 26% presented unknown
LVEF, a proportion very similar to other studies in pri-
mary care [13,14].
Table 2. Precipitating factors in the study population.
Total
N¼ 692
No hospitalisation/death at 30 d
N¼ 492
Hospitalisation/death at 30 d
N¼ 200
p ValueN (%) N (%) N (%)
Respiratory infection one week before 194 (28.2) 106 (21.7) 88 (44.0) <.001
Non-compliance with drug treatment 157 (22.8) 116 (23.7) 41 (20.7) .261
Use of NSAIDa, corticosteroids and tricyclic antidepressants 85 (12.4) 64 (13.1) 21 (10.6) .524
Other infection one week before 49 (7.1) 31 (6.3) 18 (9.0) .234
Atrial fibrillation at rate > 110 bpm 100 (14.5) 58 (11.8) 42 (21.0) <.001
Non-compliance with dietb 184 (26.8) 148 (30.3) 36 (18.2) <.001
Other arrhythmias 22 (3.1) 16 (3.2) 6 (3.0) .984
Cardiac ischaemia 37 (5.3) 22 (4.4) 15 (7.5 ) .280
Anaemia 40 (5.8) 26 (5.3) 14 (7.0) .380
aNSAID: non-steroidal anti-inflammatory drugs.
bLiquid intake of more than 2.5 l a day and/or added salt to the food.
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Table 3. Patient characteristics and precipitating factors predicting hospitalisation/death at 30 d in heart failure patients after an
episode of decompensation.
Hospitalisation/death at 30 d
Univariate odds ratio [95%
confidence interval]
Hospitalisation/death at 30 d






Men 315 (45.5) 1 (Ref.) 1 (Ref.)
Women 377 (54.5) 0.91 [0.70; 1.16] 0.99 [0.96; 1.03]
Age, yearsa 81.2 (8.9) 1.00 [0.98; 1.01] 0.99 [0.99; 1.00]
No diabetes mellitus 383 (55.3) 1 (Ref.)
Diabetes mellitus 309 (44.7) 1.32 [1.14; 1.54]
No chronic obstructive
pulmonary disease
488 (70.4) 1 (Ref.)
Chronic obstructive
pulmonary disease
204 (29.6) 1.37 [1.07; 1.74]
No dyslipidaemia 319 (43.1) 1 (Ref.)
Dyslipidaemia 373 (56.9) 1.38 [1.21; 1.58]
NHYA:b
I or II 188 (27.2) 1 (Ref.) 1 (Ref.)
III or IV 502 (72.8) 3.49 [2.36; 5.14] 1.22 [1.14; 1.29]
No hospital admission last year due
to heart failure
517 (74.6) 1 (Ref.) 1 (Ref.)
Hospital admission last year due to
heart failure
175 (25.4) 2.13 [1.76; 2.57] 1.15 [1.11; 1.19]
Ejection fraction
>¼ 50% 376 (73.4) 1 (Ref.) 1 (Ref.)
40–49% 58 (11.3) 1.46 [0.92; 2.31] 1.06 [0.98; 1.15]
<¼ 39% 78 (15.2) 2.14 [1.73; 2.65] 1.14 [1.09; 1.20]
Unknown 180 (26.0) 1.29 [0.91; 1.84] 1.06 [0.99; 1.14]
No ACE inhibitor/ARA2 179 (25.1) 1 (Ref.)
ACE inhibitor/ARA2 513 (74.9) 1.87 [1.50; 2.34]
No aldosterone antagonist 179 (77.1) 1 (Ref.)
Aldosterone antagonist 156 (22.9) 1.38 [1.18; 1,60]
Precipitating factors
No respiratory infection one
week before
498 (71.8) 1 (Ref.) 1 (Ref.)
Respiratory infection one
week before
194 (28.2) 2.84 [2.39; 3.38] 1.19 [1.14; 1.25]
No atrial fibrillation at rate >
110 bpm
592 (85.5) 1 (Ref.) 1 (Ref.)
Atrial fibrillation at rate > 110 bpm 100 (14.5) 2.17 [1.49; 3.16] 1.22 [1.09; 1.35]
Compliance diet 508 (73.2) 1 (Ref.) 1 (Ref.)
Non-compliance dietc 184 (26.8) 0.51 [0.36; 0.74] 0.90 [0.85; 0.96]
aMean (standard deviation).
bNHYA: New York Heart Association functional class.
cLiquid intake of more than 2.5 l a day and/or added salt to the food.
Table 4. Predictors of hospitalisation or death at 30 d in heart failure patients after an episode of decompensation and heart
failure hospital admission last year.
Hospital admission last year due to heart failure
No hospital admission last year due to
heart failure
Hospitalisation/death at 30 d
Multivariate odds ratio [95% confidence interval]
odds ratio
[95% confidence interval]
Hospitalisation/death at 30 d





Women 0.70 [0.49; 1.00] 1.07 [0.83; 1.36]
Age, yearsa 1.04 [1.01; 1.06] 0.99 [0.98; 1.00]
NHYAb
I or II Ref. Ref.
III or IV 5.11 [2.80; 9.34] 2.83 [1.63; 4.93]
Ejection fraction
>¼ 50% Ref. Ref.
40–49% 1.43 [0954; 2.15] 1.52 [0.84; 2.72]
<¼ 39% 2.19 [1.09; 4.42] 2.07 [1.84; 2.33]
unknown 1.15 [0.82; 1.63] 1.00 [0.55; 1.82]
Respiratory infection one week before 7.20 [5.61; 9.25] 2.10 [1.75; 2.53]
Non-compliance with dietc 0.78 [0.56; 1.10] 0.40 [0.28; 0.58]
aMean (standard deviation).
bNHYA: New York Heart Association functional class.
cLiquid intake of more than 2.5 l a day and/or added salt to the food.
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A major limitation is not having determined the
natriuretic peptides due to their low availability in pri-
mary care; even though NT-proBNP has a prognostic
value in heart failure patients with an ejection fraction
 40%. Clinical use is, however, limited as a result of
large SDs, many co-morbidities and greater age [15].
Findings in relation to other studies
To the best of our knowledge, this is the first study to
analyse the role of precipitating factors in heart failure
decompensation in primary care. Compared to previ-
ous similar studies, there was a greater proportion of
women, higher comorbidity and a larger percentage
presenting preserved ejection fraction which we attri-
bute to the higher average age of our population
[13,14,16–23]. The ratio of ACE/ARB, betablockers and
aldosterone-antagonist patients were similar to other
studies carried out in primary care [13,14].
The percentage of patients with a precipitating fac-
tor is within the range described by other authors
(between 60 and 98%) [16–20,22,23]. We found more
than one precipitating factors in more than one third
of cases, similar to Formiga et al. [17]. Given the cur-
rent variability among publications [16], the identifica-
tion of preventable precipitating factors should be
systematically assessed, as recommended in the
Standardised reporting criteria [24]. In our case, we
evaluated all the precipitating factors recommended
in this document, and we added those which seemed
to be relevant from a primary care point of view, such
as the use of detrimental drugs.
The role of respiratory infection in heart failure
decompensation has also been identified mainly in
studies undertaken in hospital emergency rooms and
internal medicine units [9,10,17–19,25]. Infections can
produce a tachycardia secondary to fever which may
shorten diastole and produce an increase in oxygen
demand, particularly in susceptible subjects, such as
those with COPD [25]. An observation confirmed in
our study where there was a higher number of events
associated with respiratory infections.
We detected that the probability of hospitalisation/
death after a respiratory infection was even greater
when patients had been admitted to hospital in the pre-
vious year, which is consistent with other authors [1].
Such finding could be explained by the fact that follow-
ing hospitalisation the previous functional level was not
fully attained, and the patients’ frailty thus increased.
Dietary transgression has also been commonly
described as a precipitating factor for heart failure
decompensation [16]. Non-compliance is often
associated with a lack of knowledge about daily intake
of liquids and salt, as well as the unanticipated
sodium content of certain foods and drugs. Real intake
could be underestimated, given that its detection is
usually based on information received from the
patients or their relatives [20]. Appropriate questioning
on salt intake by primary healthcare professionals
might present an opportunity to initiate educational
and preventive measures in this regard.
AF is also often related to heart failure decompen-
sation [16,17,21]. Fast and irregular heart rate, loss of
atrioventricular synchrony, and decrease in the contri-
bution of atrial contraction to ventricular filling make
AF a frequent trigger for decompensation [21]. In our
study, AF was identified as a possible precipitating fac-
tor in 14% of cases, a percentage slightly lower than
that described by other authors [17,21]. The propor-
tion of patients with ischemic heart disease and
hypertensive emergency that we observed in was also
lower than in other work. This could be related to a
selection bias associated with patients from hospital
emergency rooms where a greater severity of illness is
expected than in those attended in primary care.
In our study, we considered the use of non-indi-
cated/contraindicated medications as a possible cause
of decompensation, an issue which was not men-
tioned in the Standardised reporting criteria [24].
Only a few studies have analysed the role of precip-
itating factors in the prognosis of heart failure
[9,10,22,23]. We observed a 30-d mortality rate of
3.5%, lower than figures from hospital emergency
rooms and cardiology and internal medicine hospital-
isation units, where it ranged from 6 to 15%. The
same trend was found regarding hospitalisations,
which in our case did not arrive at 30%. Nevertheless,
patients treated for decompensation in emergency
room services reached almost 70%, possibly because
there are more hospitalisations than referrals or
because those in the emergency rooms have a more
severe condition.
Regarding comorbidity and decompensation short-
term prognosis, in the univariate analysis the presence
of diabetes mellitus and COPD was related to a
greater probability of admission/death. This relation-
ship however, was lost when performing the multivari-
ate analysis. The presence of these two conditions has
been related to the long-term prognosis of heart fail-
ure, particularly with ejection fraction [26], neverthe-
less, at short term other factors, such as precipitants
may play a greater role.
One of the most striking findings of the study was
that patients in whom dietary transgression had been
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identified had a lower probability of being hospitalised
or dying. A lower probability that was not observed in
those who had been hospitalised for heart failure in
the previous year. A number of studies have reported
that a dietary sodium restriction < 2 g/d provides ben-
efits only in more advanced stages, and is neutral or
even harmful in milder stages which could partly
explain our results [27]. Another possibility might be
that some patients could have been misdiagnosed as
heart failure, and they did not follow dietary restrictive
recommendations.
Meaning of the study
In a primary care study from 10 European countries,
we identified respiratory infections and rapid AF as
the most important precipitating factors for hospital-
isation and death within 30 d following an episode of
heart failure decompensation.
Patients with a hospital admission the previous
year, and a decompensation episode caused by
respiratory infection, were even more likely to be hos-
pitalised or die within 30 d.
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